In addition to these foundational approaches, Fengjie Liu and colleagues developed baicalin-loaded bifunctional albumin nanoparticles (BANPs) to increase the delivery of the natural flavonoid baicalin for the treatment of triple-negative breast cancer (TNBC). The gene discussed is ALB; the disease is triple-negative breast carcinoma.